Lawsuit Overview
June 30, 2015 (Shareholders Foundation) - An investor who currently holds shares of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), filed a lawsuit in effort to halt the proposed takeover of Kythera Biopharmaceuticals Inc by Allergan plc for a value of $75 per share is unfair to NASDAQ:KYTH stockholders. The plaintiff alleges that the defendants breached their fiduciary duties owed to...
You must register (for free) or login to view the entire case.